These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
154 related items for PubMed ID: 39407918
1. Transjugular Intrahepatic Portosystemic Shunt for Budd-Chiari Syndrome: A Single-Centre Experience. Joueidi F, Alhanaee A, Alsuhaibani H, Albenmousa A, Joueidi A, Elhassan A, Nasir AN, Marquez KAH, Alghamdi S, Al Hamoudi W, Abualganam S, Broering D, Bzeizi KI. J Clin Med; 2024 Oct 01; 13(19):. PubMed ID: 39407918 [Abstract] [Full Text] [Related]
2. Long Term Survival of Patients Undergoing TIPS in Budd-Chiari Syndrome. Sonavane AD, Amarapurkar DN, Rathod KR, Punamiya SJ. J Clin Exp Hepatol; 2019 Oct 01; 9(1):56-61. PubMed ID: 30765940 [Abstract] [Full Text] [Related]
9. Transjugular intrahepatic portosystemic shunt for severe jaundice in patients with acute Budd-Chiari syndrome. He FL, Wang L, Zhao HW, Fan ZH, Zhao MF, Dai S, Yue ZD, Liu FQ. World J Gastroenterol; 2015 Feb 28; 21(8):2413-8. PubMed ID: 25741149 [Abstract] [Full Text] [Related]
10. Budd-Chiari syndrome: long-term effect on outcome with transjugular intrahepatic portosystemic shunt. Khuroo MS, Al-Suhabani H, Al-Sebayel M, Al Ashgar H, Dahab S, Khan MQ, Khalaf HA. J Gastroenterol Hepatol; 2005 Oct 28; 20(10):1494-502. PubMed ID: 16174064 [Abstract] [Full Text] [Related]
11. Treatment of Budd-Chiari syndrome with a focus on transjugular intrahepatic portosystemic shunt. Neumann AB, Andersen SD, Nielsen DT, Holland-Fischer P, Vilstrup H, Grønbæk H. World J Hepatol; 2013 Jan 27; 5(1):38-42. PubMed ID: 23383365 [Abstract] [Full Text] [Related]
13. Timing of Transjugular Intrahepatic Portosystemic Stent-shunt in Budd-Chiari Syndrome: A UK Hepatologist's Perspective. Khan F, Mehrzad H, Tripathi D. J Transl Int Med; 2018 Sep 27; 6(3):97-104. PubMed ID: 30425945 [Abstract] [Full Text] [Related]
14. Ultrasound-guided direct intrahepatic portosystemic shunt in patients with Budd-Chiari syndrome: Short- and long-term results. Hatzidakis A, Galanakis N, Kehagias E, Samonakis D, Koulentaki M, Matrella E, Tsetis D. Interv Med Appl Sci; 2017 Jun 27; 9(2):86-93. PubMed ID: 28932502 [Abstract] [Full Text] [Related]
16. Transjugular Intrahepatic Portosystemic Shunt in Patients with Portal Hypertension: Patency Depends on Coverage and Interventionalist's Experience. Buechter M, Manka P, Gerken G, Canbay A, Blomeyer S, Wetter A, Altenbernd J, Kahraman A, Theysohn JM. Dig Dis; 2018 Jun 27; 36(3):218-227. PubMed ID: 29316565 [Abstract] [Full Text] [Related]
17. Transjugular intrahepatic portosystemic shunt for the treatment of Budd-Chiari syndrome patients: results from a single center. Fitsiori K, Tsitskari M, Kelekis A, Filippiadis D, Triantafyllou K, Brountzos E. Cardiovasc Intervent Radiol; 2014 Jun 27; 37(3):691-7. PubMed ID: 23860938 [Abstract] [Full Text] [Related]
18. TIPS for acute and chronic Budd-Chiari syndrome: a single-centre experience. Mancuso A, Fung K, Mela M, Tibballs J, Watkinson A, Burroughs AK, Patch D. J Hepatol; 2003 Jun 27; 38(6):751-4. PubMed ID: 12763367 [Abstract] [Full Text] [Related]
19. Treatment of Budd-Chiari syndrome with transjugular intrahepatic portosystemic shunt (TIPS). Corso R, Intotero M, Solcia M, Castoldi MC, Rampoldi A. Radiol Med; 2008 Aug 27; 113(5):727-38. PubMed ID: 18618075 [Abstract] [Full Text] [Related]
20. Transjugular intrahepatic portosystemic shunt (TIPS) for Budd-Chiari syndrome or portal vein thrombosis: review of indications and problems. Ganger DR, Klapman JB, McDonald V, Matalon TA, Kaur S, Rosenblate H, Kane R, Saker M, Jensen DM. Am J Gastroenterol; 1999 Mar 27; 94(3):603-8. PubMed ID: 10086638 [Abstract] [Full Text] [Related] Page: [Next] [New Search]